Circulating Heme Oxygenase-1: Not a Predictor of Preeclampsia but Highly Expressed in Pregnant Women Who Subsequently Develop Severe Preeclampsia

Table 1

General characteristics of patients enrolled in the study.

Parameters	Control	Case
		Mild	Severe
	90	16	14
Age (years)	25.9 ± 5.9	27.1 ± 5.6	29.0 ± 5.8
BMI (kg/m^2)	28.2 ± 5.3	29.4 ± 5.0	28.3 ± 5.3
Skin color (white/not white)	42/48	8/8	9/5
SBP (mmHg)	108.0 ± 11.2	114.8 ± 9.8	119.3 ± 13.4
DBP (mmHg)	65.9 ± 7.1	71.9 ± 6.5	75.9 ± 10.8
Nulliparous (%)	32 (35.0)	7 (43.7)	4 (28.6)
GA at sampling (weeks)	23.4 ± 1.5	23.6 ± 1.4	23.1 ± 1.1
GA at delivery (weeks)	39.5 ± 1.6	38.8 ± 1.1	35.1 ± 4.3^#
NBW (g)	3336.2 ± 456.2	3370.0 ± 520.9	2364.0 ± 1011.0^#
APGAR score 1 (1 min) < 7	15	2	4
APGAR score 2 (5 min) < 7	1	0	2

Information in this table is referent to the time of blood and urine collection before preeclampsia diagnosis, except for GA at delivery and NBW. Data as mean ± SD or (percentage of total). BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PE, preeclampsia; GA, gestational age; NBW, newborn weight. vs. control; ^# vs. mild case.